Senescence of human fibroblasts induced by oncogenic Raf

Genes and Development

Volumn 12, Issue 19, 1998, Pages 2997-3007

  Zhu, Jiyue ^a   Woods, Douglas ^b   McMahon, Martin ^b,c   Bishop, J Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MAP kinase signaling; Oncogenesis; Raf; Senescence

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL AGING; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; EFFECTOR CELL; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SENESCENCE; TELOMERE;

EID: 0032192153     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.19.2997     Document Type: Article

References (52)

1. Alcorta, D.A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J.C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (Ink4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. 93: 13742-13747.
2. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489-27494.
3. Avruch, J., X.F. Zhang, and J.M. Kyriakis. 1994. Raf meets Ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci. 19: 279-283.
4. Bodnar, A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner, and W.E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
5. Brown, J.P., W. Wei, and J.M. Sedivy. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834.
6. Campisi, J. 1996. Replicative senescence: An old lives' tale? Cell 84: 497-500.
7. _. 1997. The biology of replicative senescence. Eur. J. Cancer 33: 703-709.
8. Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. 92: 9363-9367.
9. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
10. Foulkes, W.D., T.Y. Flanders, P.M. Pollock, and N.K. Hayward. 1997. The CDKN2A (p16) gene and human cancer. Mol. Med. 3: 5-20.
11. Hainaut, P., T. Soussi, B. Shomer, M. Hollstein, M. Greenblatt, E. Hovig, C.C. Harris, and R. Montesano. 1997. Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acids Res. 25: 151-157.
12. Hall, M. and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-108.
13. Hara, E., R. Smith, D. Parry, H. Tahara, S. Stone, and G. Peters. 1996. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16: 859-867.
14. Hayflick, L. and P.S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621.
15. Hunter, T. 1991. Cooperation between oncogenes. Cell 64: 249-270.
16. Kamijo, T., F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
17. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548.
18. Kinsella, T.M. and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7: 1405-1413.
19. Kulju, K.S. and J.M. Lehman. 1995. Increased p53 protein associated with aging in human diploid fibroblasts. Exp. Cell Res. 217: 336-345.
20. Lees, E. 1995. Cyclin dependent kinase regulation. Curr. Biol. 7: 773-780.
21. Lin, A.W., M. Baradas, J.C. Stone, L. van Aelst, M. Serrano, and S.W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK signaling. Genes & Dev. (this issue).
22. Lloyd, A.C., F. Obermuller, S. Staddon, C.F. Barth, M. McMahon, and H. Land. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes & Dev. 11: 663-677.
23. Loughran, O., L.J. Clark, J. Bond, A. Baker, I.J. Berry, K.G. Edington, I.S. Ly, R. Simmons, R. Haw, D.M. Black, R.F. Newbold, and E.K. Parkinson. 1997. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 14: 1955-1964.
24. Marais, R., Y. Light, H. Paterson, and C.J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14: 101-110.
25. Marshall, C.J. 1994. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4: 82-89.
26. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
27. _. 1996. Ras effectors. Curr. Opin. Cell Biol. 8: 197-204.
28. McConnell, B.B., M. Starborg, S. Brookes, and G. Peters. 1998. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8: 351-354.
29. Merlo, A., J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, P.C. Burger, S.B. Baylin, and D. Sidransky. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1: 686-692.
30. Meyerson, M., C.M. Counter, E.N. Eaton, L.W. Ellisen, P. Steiner, S.D. Caddle, L. Ziaugra, R.L. Beijersbergen, M.J. Davidoff, Q. Liu, S. Bacchetti, D.A. Haber, and R.A. Weinberg. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795.
31. Miller, A.D. and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-990.
32. Morgenstern, J.P. and H. Land. 1990. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
33. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
34. O'Shea, C.C., T. Crompton, I.R. Rosewell, A.C. Hayday, and M.J. Owen. 1996. Raf regulates positive selection. Eur J. Immunol. 26: 2350-2355.
35. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. 90: 8392-8396.
36. Pomerantz, J., N. Schreiber-Agus, N.J. Liégeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H.W. Lee, C. Cordon-Cardo, and R.A. DePinho. 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723.
37. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000.
38. Reznikoff, C.A., T.R. Yeager, C.D. Belair, E. Savelieva, J.A. Puthenveettil, and W.M. Stadler. 1996. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 56: 2886-2890.
39. Samuels, M.L., M.J. Weber, J.M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13: 6241-6252.
40. Schaffner, M., B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley. 1990. The E6 oncoprotein encoded hy human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
41. Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
42. Serrano, M., A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
43. Shay, J.W. and S. Bacchetti. 1997. A survey of telomerase activity in human cancer. Eur. J. Cancer 33: 787-791.
44. Stanton, V.J., D.W. Nichols, A.P. Laudano, and G.M. Cooper. 1989. Definition of the human rat amino-terminal regulatory region by deletion mutagenesis. Mol. Cell. Biol. 9: 639-647.
45. Sugrue, M.M., D.Y. Shin, S.W. Lee, and S.A. Aaronson. 1997. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. 94: 9648-9653.
46. Takagi, S., M.L. McFadden, R.E. Humphreys, B.A. Woda, and T. Sairenji. 1993. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Cytometry 14: 640-648.
47. Thorburn, J., M. McMahon, and A. Thorburn. 1994. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J. Biol. Chem. 269: 30580-30586.
48. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8: 205-215.
49. van Steensel, B., A. Smogorzewska, and T. de Lange. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413.
50. Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Rat-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17: 5598-5611.
51. Zhang, Y., Y. Xiong, and W.G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734.
52. Zindy, F., D.E. Quelle, M.F. Roussel, and C.J. Sherr. 1997. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15: 203-211.